News & Updates
Filter by Specialty:
No benefit seen for aspirin in breast cancer
Taking aspirin in the adjuvant setting does not appear to lower the risk of recurrence or improve survival in patients with high-risk nonmetastatic breast cancer, as shown in the results of the phase III Alliance A011502 trial.
No benefit seen for aspirin in breast cancer
03 May 2024
Sexual problems remain a burden in breast cancer patients
Sexual disorders are common among breast cancer patients, and such problems may continue for up to 2 years after the cancer diagnosis, according to a study. Notably, a communication gap regarding sexuality persists between patients and healthcare providers.
Sexual problems remain a burden in breast cancer patients
03 May 2024
Dostarlimab-chemo a new SoC for endometrial cancer?
In the second interim analysis of part 1 of the phase III ENGOT-EN6-NSGO/GOG-3031/RUBY trial, dostarlimab plus carboplatin/paclitaxel (CP) chemotherapy delivered a significant survival benefit in women with primary advanced or recurrent endometrial cancer.
Dostarlimab-chemo a new SoC for endometrial cancer?
02 May 2024
Improved cervical screening uptake among local South Asian women following CUHK training
Expansion of a territory-wide cervical screening programme to train a group of local South Asian women has enabled education regarding cervical cancer and screening services among their peers, and considerably improved screening uptake.
